Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma

Cancer Science

Volumn 100, Issue 6, 2009, Pages 1018-1025

  Sun, Yan ^a   Sun, Baocun ^a   Wang, Jian ^b   Cai, Wenjuan ^c   Zhao, Xiulan ^a   Zhang, Shiwu ^a   Hao, Xishan ^b  

^a Cancer Institute and Hospital ^*  (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYBRID PROTEIN; PROTEIN SSX1; PROTEIN SSX2; PROTEIN SYT; UNCLASSIFIED DRUG; ONCOPROTEIN; PRIMER DNA; RNA; SYT SSX FUSION PROTEIN; SYT-SSX FUSION PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHINESE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE FUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SYNOVIAL SARCOMA; TREATMENT RESPONSE; TUMOR VOLUME; CANCER STAGING; CHINA; CONNECTIVE TISSUE TUMOR; GENETICS; ISOLATION AND PURIFICATION; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; RECURRENT DISEASE; RISK;

ADULT; ANTINEOPLASTIC AGENTS; CHINA; DISEASE-FREE SURVIVAL; DNA PRIMERS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO; ONCOGENE PROTEINS, FUSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SARCOMA, SYNOVIAL;

EID: 67649887764     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01134.x     Document Type: Article

References (41)

1. Kransdorf MJ. Malignant soft tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995, 164:129-34.
2. Enzinger FM, Weiss SW. Soft Tissue Tumors 1995, 3rd edn, St Louis, MO, Mosby
3. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone 2002, Lyon, France, IARC Press
4. Available from URL. 2002, http://cgapncinihgov/Chromosomes/Mitelman
5. Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 2001, 20:5755-62.
6. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: synovial sarcoma. Cancer Genet Cytogenet 2002, 133:1-23.
7. Dos Santos NR, de Bruijn DR, Geurts van Kessel A. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosom Cancer 2001, 30:1-14.
8. Panagopoulos I, Mertens F, Isaksson M. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 2001, 31:362-72.
9. Guillou L, Coindre J, Gallagher G. Detection of the synovial sarcoma translocation t(X;18) (SYT-SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol 2001, 32:105-12.
10. Kokovic I, Bracko M, Golouh R. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?. Cancer Detect Prev 2004, 28:294-301.
11. Takenaka S, Ueda T, Naka N. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Oncol Rep 2008, 19:467-76.
12. Sun B, Sun Y, Wang J. The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases. Cancer Sci 2008, 99:1355-61.
13. Sun B, Sun Y, Wang J. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev 2006, 15:258-65.
14. Trojani M, Contesso G, Coindre JM. Soft tissue sarcomas of adults: study of pathological and prognostic variables and definition of a histological grading system. Int J Cancer 1984, 33:37-42.
15. Sobin LH, Wittekind CH. International Union against Cancer: TNM Classification of Malignant Tumours 2002, 6th edn, New York, Wiley
16. Kawai A, Woodruff J, Healey JH. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998, 338:153-60.
17. Nilsson G, Skytting B, Xie Y. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999, 59:3180-4.
18. Inagaki H, Nagasaka T, Otsuka T. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma. Mod Pathol 2000, 13:482-8.
19. Mezzelani A, Mariani L, Tamborini E. SYT-SSX fusion genes and prognosis in synovial sarcoma. Br J Cancer 2001, 85:1535-9.
20. Ladanyi M, Antonescu CR, Leung DH. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002, 62:135-40.
21. Antonescu CR, Kawai A, Leung DH. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 2000, 9:1-8.
22. Lewis JJ, Antonescu CR, Leung DH. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000, 18:2087-94.
23. Trassard M, Le Doussal V, Hacene K. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol 2001, 19:525-34.
24. Spillane AJ, A'Hern R, Judson IR. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000, 18:3794-803.
25. Ferrari A, Gronchi A, Casanova M. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004, 101:627-34.
26. Guillou L, Benhattar J, Bonichon F. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol 2004, 22:4040-50.
27. Oda Y, Hashimoto H, Takeshita S. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 1993, 72:478-85.
28. Bergh P, Meis-Kindblom JM, Gherlinzoni F. Synovial sarcoma: identification of low and high risk groups. Cancer 1999, 85:2596-607.
29. Singer S, Baldini EH, Demetri GD. Synovial sarcoma: prognostic significance of tumour size, margin of resection and mitotic activity for survival. J Clin Oncol 1996, 14:1201-8.
30. Okcu MF, Despa S, Choroszy M. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy. Med Pediatr Oncol 2001, 37:90-6.
31. Deshmukh R, Mankin HJ, Singer S. Synovial sarcoma: the importance of size and location for survival. Clin Orthop 2004, 419:155-61.
32. Raney RB. Synovial sarcoma in young people: background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol 2005, 27:207-11.
33. Wright PH, Sim FH, Soule EH. Synovial sarcoma. J Bone Joint Surg [Am] 1982, 64:112-22.
34. Mullen JR, Zagars GK. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol 1994, 33:23-30.
35. Brodsky JT, Burt ME, Hadju SI. Synovial sarcoma. Clinicopathological features, treatment and prognosis. Cancer 1992, 70:484-9.
36. Rooser BO, Willen H, Hugoson A. Prognostic factors in synovial sarcoma. Cancer 1989, 63:2182-5.
37. Golouh R, Vuzevski V, Bracko M. Synovial sarcoma: a clinicopathological study of 36 cases. J Surg Oncol 1990, 45:20-8.
38. Cohen HJ. Biology of aging as related to cancer. Cancer 1994, 74:2092-100.
39. Choong PFM, Pritchard DJ, Sim FH. Long-term survival in high grade soft tissue sarcoma: prognostic factors in synovial sarcoma. Int J Oncol 1995, 7:161-9.
40. Kampe CE, Rosen G, Eilber F. Synovial sarcoma: a study of intensive chemotherapy in 14 patients with localized disease. Cancer 1993, 72:2161-9.
41. Brecht IB, Ferrari A, Int-Veen C. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies. Pediatr Blood Cancer 2006, 46:11-17.